🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
The primary objective of this study is to assess and compare the pharmacoki...
Status
Completed
Location
Teva Investigational Site 32170
Start Date
2013-01
Trial ID
NCT01785433
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
Main study: To investigate safety, tolerability, pharmacodynamics (PD) and ...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT02263976
Treatments Being Tested
Rationale for the current trial is to demonstrate 24 hour bronchodilator ef...
Status
Completed
Location
205.420.43002 Boehringer Ingelheim Investigational Site
Start Date
2010-07
Trial ID
NCT01152450
Treatments Being Tested
The primary objective of this study is to evaluate long-term safety and pat...
Status
Completed
Location
1012.62.153 Boehringer Ingelheim Investigational Site
Start Date
2009-11
Trial ID
NCT01019694
Treatments Being Tested
Study to demonstrate that at least one of the two doses of Berodual® (50 µg...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02182505
Treatments Being Tested
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.14.01404 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01533935
Treatments Being Tested
Randomized, Phase IIIb, Three-period, Three-treatment, Double-blind, Multi-...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-01
Trial ID
NCT02347072
Treatments Being Tested
The primary objective of this trial is to evaluate the efficacy and safety ...
Status
Completed
Location
205.424.01002 Boehringer Ingelheim Investigational Site
Start Date
2010-05
Trial ID
NCT01122680
Treatments Being Tested